naa a22 4500 510741207 CHVBK 20180411083028.0 cr unu---uuuuu 180411e20131201xx s 000 0 eng 10.1007/s11845-013-0939-5 doi (NATIONALLICENCE)springer-10.1007/s11845-013-0939-5 A study of glycogen storage disease with 99Tcm-MIBI gated myocardial perfusion imaging [Elektronische Daten] [L. Wei, J. Gao, X. Liu, J. Huang, X. Li] Objective: Gated myocardial perfusion imaging (G-MPI) is regularly performed using single-photon emission computed tomography. The objective of this study was to evaluate the clinical value of 99Tcm-methoxyisobutylisonitrile (MIBI) myocardial imaging in glycogen storage disease (GSD). Methods: 99Tcm-MIBI G-MPI was performed in nine patients with clinically proven GSD. QGS quantitative software was used for processing and interpretation. Left ventricular ejection fraction (LVEF), end-diastolic volume (EDV) and end-systolic volume (ESV) were automatically generated. The myocardium was divided into seven segments, 20 sub-segments and a five-point scoring system was used. Results: Seven out of nine cases were abnormal and the positive rate of G-MPI was 77.8%. Sixty-two sub-segments of injured myocardium were detected in 140 sub-segments of seven abnormal patients. One injured segment was observed in one patient (14.3%), two segments were detected in two patients (28.6%) and three or more abnormal segments were observed in four patients (57.1%). Conclusion: 99Tcm-MIBI G-MPI can detect myocardial damage in GSD as a non-invasive method. It plays an important role in the clinic. Royal Academy of Medicine in Ireland, 2013 Glycogen storage disease nationallicence Tomography nationallicence Emission computed nationallicence Single-photon nationallicence MIBI nationallicence Wei L. Department of Nuclear Medicine, The Third Affiliated Hospital of Hebei Medical University, 050051, Shijiazhuang, China aut Gao J. Department of Nuclear Medicine, The Third Affiliated Hospital of Hebei Medical University, 050051, Shijiazhuang, China aut Liu X. Department of Nuclear Medicine, The Third Affiliated Hospital of Hebei Medical University, 050051, Shijiazhuang, China aut Huang J. Department of Nuclear Medicine, The Third Affiliated Hospital of Hebei Medical University, 050051, Shijiazhuang, China aut Li X. Department of Nuclear Medicine, The Third Affiliated Hospital of Hebei Medical University, 050051, Shijiazhuang, China aut Irish Journal of Medical Science Springer London 182/4(2013-12-01), 615-620 0021-1265 182:4<615 2013 182 11845 https://doi.org/10.1007/s11845-013-0939-5 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s11845-013-0939-5 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Wei L. Department of Nuclear Medicine, The Third Affiliated Hospital of Hebei Medical University, 050051, Shijiazhuang, China aut NATIONALLICENCE 700 1- Gao J. Department of Nuclear Medicine, The Third Affiliated Hospital of Hebei Medical University, 050051, Shijiazhuang, China aut NATIONALLICENCE 700 1- Liu X. Department of Nuclear Medicine, The Third Affiliated Hospital of Hebei Medical University, 050051, Shijiazhuang, China aut NATIONALLICENCE 700 1- Huang J. Department of Nuclear Medicine, The Third Affiliated Hospital of Hebei Medical University, 050051, Shijiazhuang, China aut NATIONALLICENCE 700 1- Li X. Department of Nuclear Medicine, The Third Affiliated Hospital of Hebei Medical University, 050051, Shijiazhuang, China aut NATIONALLICENCE 773 0- Irish Journal of Medical Science Springer London 182/4(2013-12-01), 615-620 0021-1265 182:4<615 2013 182 11845 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer